CN Patent

CN101111492B — 吲哚衍生物

Assigned to Tanabe Pharma Corp · Expires 2010-09-22 · 16y expired

What this patent protects

具下式(I)的新颖的吲哚衍生物或其医药上可接受的盐，式中R 1 为卤素、或烷基，R 2 为氢、或卤素，Ar为苯基、或噻吩基，其可用卤素、烷基、烷氧基、烷硫基等取代。

USPTO Abstract

具下式(I)的新颖的吲哚衍生物或其医药上可接受的盐，式中R 1 为卤素、或烷基，R 2 为氢、或卤素，Ar为苯基、或噻吩基，其可用卤素、烷基、烷氧基、烷硫基等取代。

Drugs covered by this patent

Patent Metadata

Patent number
CN101111492B
Jurisdiction
CN
Classification
—
Expires
2010-09-22
Drug substance claim
No
Drug product claim
No
Assignee
Tanabe Pharma Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.